OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Cardiovascular Diseases is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
CTA in roadmapping post-CABG evaluation	470
List of recent issues	276
Table of contents	153
Updates in fluorodeoxyglucose positron emission tomography (18FDG-PET) in the diagnosis and management of cardiac sarcoidosis	108
COVID-19 and coronary atherosclerosis: Unmasking and accelerating?	106
Emerging tracers for cardiac imaging: Innovations and clinical implications	93
Physical activity, fitness, and longevity	92
Use of mechanical circulatory support in high-risk percutaneous coronary interventions	91
Cover 2 (Masthead)	73
Table of contents	63
Cover 2 (Masthead)	63
Cover 2 (Masthead)	60
List of recent issues	58
Table of contents	53
Cover 2 (Masthead)	52
Multimodality imaging of hypertrophic cardiomyopathy	48
Estrogen and cardiovascular disease	43
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?	43
Handgrip strength asymmetry increases risk of all-cause and cardiovascular mortality: A dose-response analysis across 28 countries	42
Updates on obesity and the obesity paradox in cardiovascular diseases	42
Evidence to support health system prioritization of health behaviors in the COVID-19 era	40
List of recent issues	37
Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing	37
Timing of transcatheter aortic valve replacement after balloon aortic valvuloplasty: Insights from a multicenter real-world cohort	37
Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID – Best practice approaches	37

Editorial Board	37
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy	37
List of recent issues	35
Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio	35
Cover 2 (Masthead)	34
A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus	33
Transthyretin amyloid cardiomyopathy: Evolving therapies, expanding hope	33
Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a “cholesterol paradox?”	32
The weekly mortality for ischemic heart disease in the US still peaks on mondays	32
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis	32
Updates on inherited arrhythmia syndromes (Brugada syndrome, long QT syndrome, CPVT, ARVC)	31
Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study	31
Impact of age on the utility of CardioMEMS device in reducing heart failure readmissions	29
Normative values for body composition in 22,191 healthy Norwegian adults 20–99 years: The HUNT4 study	29
Table of contents	28
Table of contents	27
Editorial Board	27
Antegrade techniques for chronic total occlusion percutaneous coronary intervention	26
No second chances: Cardiovascular death is the most frequent incident event among patients with coronary artery calcium	26
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation	26
Moving beyond what the eye can see: Subclinical disease, comprehensive diagnosis, and emerging therapeutics	26
Incidence of acute myocardial infarction and hurricane Katrina: Fourteen years after the storm	26
Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men	26
Improving outcomes in severe mitral regurgitation due to annular calcification	25
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)	25
The polypill strategy in cardiovascular disease prevention: It's time for its implementation	24
Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword	22
Reflections on community experience with Mavacamten	22
The new life of myectomy in the era of myosin inhibitors	22
The connection between sleep deficiency and coronary artery disease: Complexities and controversies	22
Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment	22
Clinical pearls and emerging science: Highlights from this issue	20
Cover 2 (Masthead)	20
Of meat & molecules	20
Leisure time versus occupational physical activity for cardiometabolic risk	19
HCM's hidden cost: The impact of socioeconomic status	19
Unmet needs and future directions in hypertrophic cardiomyopathy	19
Table of contents	19
Generalizability of SURPASS-CVOT to the United States: A Nationally Representative Study	18
Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program	18
Exercise and cardiovascular health: A state-of-the-art review	18
Different right ventricular dysfunction and pulmonary coupling in acute heart failure according to the left ventricular ejection fraction	18
Treatment adherence patterns for patients with atherosclerotic cardiovascular disease: Patient and provider perspectives	18
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience	18
Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation	18
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Exam	18
Redefining nuclear cardiology: Bridging innovation, evidence, and practice	17
Predicting life expectancy in the United States: The importance of healthy living behaviors and residential geography	17
The culture of healthy living – Exploring the chaos that drives health behaviors	17
Table of contents	17

Recognizing risk factors associated with poor outcomes among patients with COVID-19	17
Impact of mitral valve intervention and frailty on outcomes of severe mitral regurgitation due to severe mitral annular calcification	16
Adipo-cardiology: The next frontier in cardiovascular disease	16
Catheter ablation as first line therapy for atrial fibrillation	16
Beyond the treadmill: The evolving role of coronary CTA in perioperative risk stratification	16
Efficacy and safety of cardiac myosin inhibitors in obstructive hypertrophic cardiomyopathy: Systematic review and comprehensive frequentist and Bayesian meta-analyses of Phase 3 randomized controlled	16
Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants	15
Comparison of risk profiles of participants in the Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary A	15
Dose-response associations of the American Heart Association's new “Life's essential 8” metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States	15
Self-reported walking pace and 10-year cause-specific mortality: A UK biobank investigation	15
Large language models in sports cardiology: Challenges, governance, and human-in-the-loop integration	15
Systems science approaches to cardiovascular disease prevention and management in the era of COVID-19: A Humpty-Dumpty dilemma?	15
Debunking the vegan myth: The case for a plant-forward omnivorous whole-foods diet	15
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin	15
The physiologic benefits of optimizing cardiorespiratory fitness and physical activity – From the cell to systems level in a post-pandemic world	14
Popular fad diets: An evidence-based perspective	14
Editorial Board	14
Optical coherence tomography angiography in cardiovascular disease	14
A successful home-based cardiac rehabilitation program in the early phase of the COVID-19 pandemic	14
Effect of BMI on patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis	13
The fit-fat index: Is it fitness or fatness or both that predicts sudden cardiovascular death?	13
Clinical outcomes following TAVR for patients with low and very low gradient aortic stenosis	13
Can the outlier percentiles from norms increase the sensitivity of the ECG criteria for screening athletes?	13
Health equity in heart failure	13
RSV in cardiovascular care: When the lungs speak to the heart	13
Association of neighborhood median income to outcomes in hypertrophic cardiomyopathy	13
Statin associated muscle symptoms: An update and review	12
Differential effects of overweight/obesity depending on the severity of heart failure complicating acute myocardial infarction in Japan	12
Cardiorespiratory fitness and physical activity in the lens of social justice – Reporting on the disparities that exist	12
CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in ischemic dilated CardioMyopathy: Prognostic implication of papillary muscles involvement	12
Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy	12
Subclinical atherosclerosis on chest computed tomography and mortality in young patients with severe hypercholesterolemia	12
COVID-19, Unhealthy lifestyle behaviors and chronic disease in the United States: Mapping the social injustice overlay	12
Prioritizing the primary prevention of heart failure: Measuring, modifying and monitoring risk	11
Dietary dilemmas	11
Editorial Board	11
Digital care in your pocket: The role of technology in exercise, fitness, prevention, and rehabilitation	11
Multimodality imaging approaches for diagnosis of cardiac amyloidosis	11
Social determinants of health, health disparities, and adiposity	11
The role of 18F-fluorodeoxyglucose positron emission tomography for vascular imaging	11
Building a culture of healthy living in the workplace	11
Editor handoff PCVD	11
Circulating microRNA signatures associated with atrial remodeling in endurance athletes with PAFIYAMA syndrome: A case–control study	11
Pulsed field ablation: The basics relating to effectiveness, durability, and safety	11
List of recent issues	11
Clinical conundrums involving statin drug-drug interactions	11
Evaluation of the PREVENT risk assessment tool and visceral adiposity: Insights from the UK Biobank	10
Insight into different phenotypic presentations of heart failure with preserved ejection fraction	10
Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective	10
Caution: very high HDL-cholesterol	10
Cover 2 (Masthead)	10
How to facilitate smoking cessation	10
Artificial intelligence in nuclear cardiology: Enhancing diagnostic accuracy and efficiency	10
Complications of percutaneous coronary intervention	10